(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/buy_a_domain.png

Buy and register domain names online from CRWE Domains. Web hosting, spam-free email, web marketing, secure SSL Certificates and more

www.crwedomains.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






638 Result: Form 10-K

Crown Equity Holdings, Inc. Engages Attorney Arnold F. Sock as Securities Counsel

May 01st, 2018

LAS VEGAS, NV / CRWE PRESS RELEASE / April 30, 2018 - Crown Equity Holdings, Inc. (Pink Sheets: CRWE) announced today that the company has engaged Attorney Arnold F. Sock as securities counsel. Mr. Sock has extensive senior level management abilities. Read more

American Video Teleconferencing Corp. Engages Attorney Arnold F. Sock as Securities Counsel

April 30th, 2018

LAS VEGAS, NV / CRWE PRESS RELEASE / April 30, 2018 - American Video Teleconferencing Corp. (Pink Sheets: AVOT) announced today that the company has engaged Attorney Arnold F. Sock as securities counsel. Mr. Sock has extensive senior level management. Read more

Puma Biotechnology Announces European Medicines Agency Validation of Marketing Authorization Application for PB272 (Neratinib) as Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer in Europe

August 22nd, 2016

LOS ANGELES, Calif. / CRWE PRESS RELEASE / August 22, 2016 - Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that the Marketing Authorization Application (MAA) for neratinib has been validated by the European Medicines A. Read more

Cesca Therapeutics Announces Promising Results From 40-Month Follow-Up of Patients Enrolled in Critical Limb Ischemia Feasibility Study

August 03rd, 2016

Rancho Cordova, Calif. / CRWE PRESS RELEASE / August 03, 2016 - Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced 40-month follow-up results for a number of patients that particip. Read more

EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Post-Operative Inflammation and Pain in Cataract Surgery Patients

August 01st, 2016

WALTHAM, Mass. / CRWE PRESS RELEASE / Aug. 01, 2016 — EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing produ. Read more

Shire Recommends ADS Holders Reject TRC Capital's "Mini-Tender Offer"

July 29th, 2016

Dublin, Ireland / CRWE PRESS RELEASE / July 29, 2016 – Shire plc (LSE: SHP) (NASDAQ: SHPG) has been notified of an unsolicited “mini-tender” offer made by TRC Capital Corporation (“TRC Capital”) to purchase up to 1,000,0. Read more

Anavex Presents 31-Week Efficacy Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients at AAIC 2016

July 27th, 2016

Sustained Response Through 31 Weeks for both Cognitive (MMSE) and Functional (ADCS-ADL) Measures NEW YORK, NY / CRWE PRESS RELEASE / July 27, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL. Read more

Verizon to acquire Yahoo's operating business

July 25th, 2016

Transaction will create a new rival in mobile media technology reaching over 1B users* with an unrivaled roster of the world’s most beloved brands BASKING RIDGE, NJ, and SUNNYVALE, Calif. / CRWE PRESS RELEASE / July 25, 2016 &ndash. Read more

ONIVYDE(R) Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas who have Progressed Following Gemcitabine based Therapy

July 25th, 2016

The positive opinion is based on a pivotal Phase 3 study showing that ONIVYDE combined with chemotherapy significantly increased overall survival (OS) in patients with metastatic pancreatic cancer after previous gemcitabine based therapy Zug, Swit. Read more

Anavex Presents 31-Week Safety Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients at AAIC 2016

July 24th, 2016

Results Feature Favorable Safety, Maximum Tolerated Dose, Positive Dose Response as well as Positive Unexpected Therapeutic Response Events NEW YORK, NY / CRWE PRESS RELEASE / July 24, 2016 – Anavex Life Sciences Corp. (“Anavex” . Read more

Puma Biotechnology Announces Interim 5-Year Disease Free Survival Data from Phase III Trial of PB272 (Neratinib) in Extended Adjuvant HER2-Positive Early Stage Breast Cancer (ExteNET Trial)

July 21st, 2016

LOS ANGELES, Calif. / CRWE PRESS RELEASE / July 21, 2016 - Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced updated results from the Phase III clinical trial of Puma's investigational drug PB272 (neratinib) for t. Read more

CP reaches agreement with future CEO, Keith Creel; retains services of E. Hunter Harrison beyond retirement

July 21st, 2016

Calgary, AB / CRWE PRESS RELEASE / July 20, 2016 - Canadian Pacific Railway Limited (TSX: CP) (NYSE: CP) today announced that CP's Board of Directors has reached an agreement with CP's next chief executive officer, Keith Creel. Currently pres. Read more

Joy Global Announces Agreement to Be Acquired by Komatsu in $3.7 Billion All-Cash Transaction

July 21st, 2016

Delivers substantial all-cash premium to Joy Global stockholders Komatsu committed to long-term growth of Joy Global, which will operate as a separate subsidiary of Komatsu Milwaukee, WI / CRWE PRESS RELEASE / July 21, 2016 - Joy Global Inc. (N. Read more

Transgenomic Licenses Commercial Rights to Its Long QT Syndrome DNA Testing Portfolio to LabCorp

July 20th, 2016

LabCorp’s DNA Testing for Long QT Syndrome, a Congenital Heart Rhythm Disorder Associated with Potentially Lethal Arrhythmias, is Enhanced by TBIO’s Intellectual Property OMAHA, NE / CRWE PRESS RELEASE / July 20, 2016 - Transgenom. Read more

ANI Pharmaceuticals Announces FDA Approval and Immediate Launch of Nilutamide Tablets, the First Generic Competitor to Nilandron(R)

July 18th, 2016

BAUDETTE, Minnesota / CRWE PRESS RELEASE / July 18, 2016 - ANI Pharmaceuticals, Inc. (“ANI”) (Nasdaq: ANIP) today announced that it has received approval from the U.S. Food and Drug Administration (“FDA”) of the Abbreviated Ne. Read more

Load More Content